101 invited speakers from 21 countries at EACPT Geneva Congress 28-31 August 2013

For the 11th biennnial EACPT Congress to be held in Geneva, 28th-31st August, there will be 101

invited speakers from 21 countries - 15 from the European region and a further 6 countries internationally, from the USA, Canada, New Zealand, China, Benin and India. Abstract submission is now closed: around 400 abstracts have been submitted from 57 countries from all 5 continents for consideration for oral and poster communications. Key themes at the Geneva congress will range from bedside pharmacology for special patient groups, to pharmacology & toxicology, and pharmacology and society. 
 

For more on the Geneva Congress, see the latest news from the EACPT Executive Committee -

EACPT EC at Hôpital St Antoine in Paris

which met in Paris 18th - 20th April [Picture shows EACPT EC members from Holland, UK, Croatia, Italy, Hungary, France, Spain, Sweden and Switzerland]. 

To register for the Geneva EACPT Congress, go to the Congress website.

EACPT Geneva 2013: Symposium on treating rare inborn errors of metabolism : from theory to practice

Abstract submission is now open for the next EACPT Congress, to be held in Geneva 28-31 August 2013. The congress includes symposia, keynote lectures and peer-reviewed oral and poster communications.

Symposium on treating rare inborn errors of metabolism : from theory to practice

Inborn errors of metabolism represent a relatively new and rapidly expanding class of genetic diseases. Signs and symptoms can affect all organs and may start at any age, from infancy to old age. Tremendous advances in laboratory techniques have led the way to the identification of hundreds of different diseases, requiring development of very diverse new therapeutic approaches, such as enzyme replacement or pharmacological chaperone therapies.

Inborn errors of metabolism offer not only new niches for orphan drug developers, but also models to get a better understanding of physiological pathways that play a role in many, more common diseases.

2013 EACPT Congress
Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals, and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.

See here for more on key themes of the Congress.

EACPT Geneva 2013 Congress website  www.eacpt2013.org

EACPT Geneva 2013: Symposium on Predictive Pharmacogenetics

-->

Abstract submission is now open for the next EACPT Congress, to be held in Geneva 28-31 August 2013. The congress includes symposia, keynote lectures and peer-reviewed oral and poster communications.

Symposium on Predictive Pharmacogenetics
In current clinical practice, the majority of drugs are given at a standardized dose that is sometimes followed by individual titration according to the physician’s experience, and to the patient’s related disease conditions, co-morbidities and co-medications. The knowledge of genetic modulation of therapeutic targets and of metabolism and transport of drugs has increased over the last decade so that individualized therapy adjusted to the patient’s genetic background has moved closer to reality. This session will be devoted to examine, with two outstanding experts, the validity of this issue in psychiatric and cardiovascular diseases, two main therapeutic challenges for the forthcoming century.

2013 EACPT Congress
Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals, and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.

See here for more on key themes of the Congress.

EACPT Geneva 2013 Congress website  www.eacpt2013.org

EACPT Geneva 2103: Symposium on Personalizing Cancer Therapy

Abstract submission is now open for the next EACPT Congress, to be held in Geneva 28-31 August 2013. The congress includes symposia, keynote lectures and peer-reviewed oral and poster communications.

Symposium on Personalizing Cancer Therapy

Inter-individual differences in patient responses to cancer therapies are consistently observed. Personalizing cancer therapy refers to individualized cancer patient management driven by host and tumor characteristics. Both organ dysfonction and genetic alterations in drug disposition and targets may result in suboptimal treatment or excessive toxicity. Therefore, personalized cancer therapy ultimately aims at selecting the right drug and dose for the right patient. The genetic characteristics of a tumor may also guide treatment and molecular targeted therapies have indeed been a major breakthrough in oncology.

In this session, co-organized by the American Society of Clinical Pharmacology and Therapeutics (ASCPT), three world-renowned experts will examine the latest developments in tailoring cancer therapies, with a focus on individualizing therapies in special populations, hematological malignancies and breast cancer.

2013 EACPT Congress

Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals, and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.

See here for more on key themes of the Congress.

EACPT Geneva 2013 Congress website  www.eacpt2013.org

EACPT 2013 Geneva: Networking in Clinical Toxicology

Abstract submission is now open for the next EACPT Congress, to be held in Geneva 28-31 August 2013. The congress includes symposia, keynote lectures and peer-reviewed oral and poster communications.

Symposium on Networking in Clinical Toxicology
Various fields in the area of clinical toxicology exist, covering topics such as emergency medicine, intensive care, analytical and forensic toxicology, teratology, occupational and environmental medicine, prevention, and regulatory toxicology. Poisons Centres which serve as national telephone hotlines in toxic emergencies, keep contacts and collaborate closely with experts of all these areas of clinical toxicology, in order to be able to give expert advice to members of the general public and medical professionals, for questions of clinical management, diagnostic and therapeutic procedures, antidote provision and use, prognosis in acute poisoning, toxico-epidemiology and toxico-vigilance.

2013 EACPT Congress

Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals, and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.

See here for more on key themes of the Congress.

EACPT Geneva 2013 Congress website  www.eacpt2013.org

EACPT Geneva 2013: Updates in Clinical Toxicology

Abstract submission is now open for the next EACPT Congress, to be held in Geneva 28-31 August 2013. The congress includes symposia, keynote lectures and peer-reviewed oral and poster communications.

Symposium on Updates in Clinical Toxicology

New medicines, new therapeutic principles, development of new chemical substances, new illicit drugs are all challenges for Poisons Centres and clinical toxicologists in Europe and elsewhere. All these represent new risks for accidental, intentional, occupational, and abusive exposures to an ever increasing number of agents. Research in clinical toxicology leads to new antidote treatments and insights into toxic mechanisms. As large studies are often difficult to perform in human toxicity, careful diagnostic workup of individual cases will sometimes reveal surprising results, even in well known substances such as dioxin or paracetamol.

2013 EACPT Congress

Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals, and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.

See here for more on key themes of the Congress.

EACPT Geneva 2013 Congress website  www.eacpt2013.org

EACPT Geneva 2013: Symposium on training tomorrow’s prescribers

Abstract submission is now open for the next EACPT Congress, to be held in Geneva 28-31 August 2013. The congress includes symposia, keynote lectures and peer-reviewed oral and poster communications.

Symposium on training tomorrow’s prescribers

There is growing evidence that prescribing errors are common and cause avoidable ineffective treatments, adverse drug reactions, hospital admissions, and discomfort to patients. It is also recognized that not enough time is devoted to undergraduate and postgraduate teaching in CPT, which is unfortunate because it is difficult to correct bad prescribing habits once they have been developed.

In order to ‘immunize’ future prescribers against making these errors, this symposium addresses two key issues: clinical workplace learning and assessment. First, undergraduate and postgraduate students should be trained in therapeutics and prescribing in a structured manner during their clinical clerkships and residency. This so-called clinical workplace learning is essential, because during this period students acquire prescribing skills and habits. Secondly, the prescribing skills and performance of students should be assessed throughout the undergraduate and postgraduate teaching period in order to establish a positive learning curve.

2013 EACPT Congress

Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals, and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.

See here for more on key themes of the Congress.

EACPT Geneva 2013 Congress website  www.eacpt2013.org